Literature DB >> 2431267

Vaccinia virus growth factor stimulates tyrosine protein kinase activity of A431 cell epidermal growth factor receptors.

C S King, J A Cooper, B Moss, D R Twardzik.   

Abstract

Infection of A431 cells with vaccinia virus, or exposure to a mitogenic polypeptide secreted by vaccinia virus-infected cells, induces tyrosine phosphorylation of epidermal growth factor receptors.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2431267      PMCID： PMC367516          DOI： 10.1128/mcb.6.1.332-336.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN： 0270-7306            Impact factor:   4.272


  36 in total

1.  Synthesis of biologically active rat transforming growth factor I.

Authors:  J P Tam; H Marquardt; D F Rosberger; T W Wong; G J Todaro
Journal:  Nature       Date:  1984 May 24-30       Impact factor: 49.962

2.  C-kinase phosphorylates the epidermal growth factor receptor and reduces its epidermal growth factor-stimulated tyrosine protein kinase activity.

Authors:  C Cochet; G N Gill; J Meisenhelder; J A Cooper; T Hunter
Journal:  J Biol Chem       Date:  1984-02-25       Impact factor: 5.157

3.  Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.

Authors:  A Ullrich; L Coussens; J S Hayflick; T J Dull; A Gray; A W Tam; J Lee; Y Yarden; T A Libermann; J Schlessinger
Journal:  Nature       Date:  1984 May 31-Jun 6       Impact factor: 49.962

4.  Tumor promoters block tyrosine-specific phosphorylation of the epidermal growth factor receptor.

Authors:  B Friedman; A R Frackelton; A H Ross; J M Connors; H Fujiki; T Sugimura; M R Rosner
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

5.  Phorbol ester-induced threonine phosphorylation of the human epidermal growth factor receptor occurs within the EGF binding domain.

Authors:  M Chinkers; D L Garbers
Journal:  Biochem Biophys Res Commun       Date:  1984-09-17       Impact factor: 3.575

6.  Glycosylation of the epidermal growth factor receptor in A-431 cells. The contribution of carbohydrate to receptor function.

Authors:  A M Soderquist; G Carpenter
Journal:  J Biol Chem       Date:  1984-10-25       Impact factor: 5.157

7.  Autophosphorylation sites on the epidermal growth factor receptor.

Authors:  J Downward; P Parker; M D Waterfield
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

8.  Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane.

Authors:  T Hunter; N Ling; J A Cooper
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

9.  Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity.

Authors:  G N Gill; T Kawamoto; C Cochet; A Le; J D Sato; H Masui; C McLeod; J Mendelsohn
Journal:  J Biol Chem       Date:  1984-06-25       Impact factor: 5.157

10.  Antibodies to the epidermal growth factor receptor block the biological activities of sarcoma growth factor.

Authors:  G Carpenter; C M Stoscheck; Y A Preston; J E DeLarco
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205
View more
  21 in total

1.  Activation of cJUN N-terminal kinase by herpes simplex virus type 1 enhances viral replication.

Authors:  T I McLean; S L Bachenheimer
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  The genome of Shope fibroma virus, a tumorigenic poxvirus, contains a growth factor gene with sequence similarity to those encoding epidermal growth factor and transforming growth factor alpha.

Authors:  W Chang; C Upton; S L Hu; A F Purchio; G McFadden
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

3.  Deletion of the vaccinia virus growth factor gene reduces virus virulence.

Authors:  R M Buller; S Chakrabarti; J A Cooper; D R Twardzik; B Moss
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

4.  Characterization of vaccinia virus growth factor biosynthetic pathway with an antipeptide antiserum.

Authors:  W Chang; J G Lim; I Hellström; L E Gentry
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

5.  The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors.

Authors:  R J Mervis; N Ahmad; E P Lillehoj; M G Raum; F H Salazar; H W Chan; S Venkatesan
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

6.  Multiple 3' ends of mRNA encoding vaccinia virus growth factor occur within a series of repeated sequences downstream of T clusters.

Authors:  L Yuen; B Moss
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

7.  Reovirus infection activates JNK and the JNK-dependent transcription factor c-Jun.

Authors:  P Clarke; S M Meintzer; C Widmann; G L Johnson; K L Tyler
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

8.  The epidermal growth factor receptor is not a receptor for vaccinia virus.

Authors:  A W Hügin; C Hauser
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  Mapping and sequencing of a gene from myxoma virus that is related to those encoding epidermal growth factor and transforming growth factor alpha.

Authors:  C Upton; J L Macen; G McFadden
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

10.  ERK- and JNK-dependent signaling pathways contribute to Bombyx mori nucleopolyhedrovirus infection.

Authors:  Susumu Katsuma; Kazuei Mita; Toru Shimada
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.